Suchergebnisse - Alain Moussy

Treffer weiter einschränken
  1. 1
    ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?

    ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? von D. S. Petrov, Colin D. Mansfield, Alain Moussy, Olivier Hermine

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

    Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study von Patrick Vermersch, R. Benrabah, Nicolás Schmidt, Hélène Zephir, Pierre Clavelou, Cyrille Vongsouthi, Patrice Dubreuil, Alain Moussy, Olivier Hermine

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors

    Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors von Sébastien Létard, Ying Yang, Katia Hanssens, Fabienne Palmérini, Phillip S. Leventhal, Stéphanie Guéry, Alain Moussy, Jean‐Pierre Kinet, Olivier Hermine, Patrice Dubreuil

    Veröffentlicht 2008
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy

    Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy von Daniela Silva Moura, Serge Sultan, Sophie Georgin‐Lavialle, N. Pillet, François Montestruc, Paul Gineste, Stéphane Barète, Gandhi Damaj, Alain Moussy, Olivier Lortholary, Olivier Hermine

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model

    Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model von Martine Humbert, Nathalie Castéran, Sébastien Létard, Katia Hanssens, Juan Iovanna, Pascal Finetti, François Bertucci, Thomas Bader, Colin D. Mansfield, Alain Moussy, Olivier Hermine, Patrice Dubreuil

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

    Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial von Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Long-term survival analysis of masitinib in amyotrophic lateral sclerosis

    Long-term survival analysis of masitinib in amyotrophic lateral sclerosis von Jesús S. Mora, Walter G. Bradley, Delia Chaverri, María Hernández-Barral, Javier Mascías, Josep Gámez, Gisella Gargiulo‐Monachelli, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Albert C. Ludolph

    Veröffentlicht 2021
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

    Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial von F. Piette, Joël Belmin, H. Vincent, Nicolás Schmidt, Sylvie Pariel, Marc Verny, Caroline Marquis, Jean Mely, Laurence Hugonot-Diener, Jean‐Pierre Kinet, Patrice Dubreuil, Alain Moussy, Olivier Hermine

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

    Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study von Jacques Tébib, Xavier Mariette, Pierre Bourgeois, René‐Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D. Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

    Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study von C. Paul, B. Sans, Felipe Suárez, Philippe Casassus, Stéphane Barète, Fanny Lanternier, Catherine Grandpeix‐Guyodo, Patrice Dubreuil, Fabienne Palmérini, Colin D. Mansfield, Paul Gineste, Alain Moussy, Olivier Hermine, Olivier Lortholary

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors

    Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors von K. Hahn, G. Oglivie, Todd Rusk, Patrick Devauchelle, Amy K. LeBlanc, Alfred Μ. Legendre, B.E. Powers, Phillip S. Leventhal, Jean-Pierre Kinet, F. Palmerini, Patrice Dubreuil, Alain Moussy, Olivier Hermine

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

    A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer von G. Deplanque, Martin Demarchi, Mohamed Hebbar, Patrick J. Flynn, Bohuslav Melichar, J. Atkins, Elżbieta Nowara, Lem Moyé, David Piquemal, D. Ritter, Patrice Dubreuil, Colin D. Mansfield, Y. Acin, Alain Moussy, Olivier Hermine, Pascal Hammel

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

    Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT von Patrice Dubreuil, Sébastien Létard, Marco A. Ciufolini, Laurent Gros, Martine Humbert, Nathalie Castéran, Laurence Borge, Bérengère Hajem, Anne Lermet, Wolfgang Sippl, Edwige Voisset, Michel Arock, Christian Auclair, Phillip S. Leventhal, Colin D. Mansfield, Alain Moussy, Olivier Hermine

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors

    Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors von Hahn K.A., Legendre A.M., Shaw N.G., Brenda Phillips, Ogilvie G.K., Prescott D.M., Atwater S.W., Carreras J.K., Lana S.E., Tracy A. LaDue, A. Usk, Kinet J.P., Patrice Dubreuil, Alain Moussy, Olivier Hermine

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis

    Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis von Olivier Hermine, Olivier Lortholary, Phillip S. Leventhal, Adeline Catteau, Frédérique Soppelsa, Cédric Baude, Annick Cohen-Akenine, Fabienne Palmérini, Katia Hanssens, Ying Yang, Hagay Sobol, Sylvie Fraytag, David Ghez, Felipe Suárez, Stéphane Barète, Philippe Casassus, Sans Beatrice, Michel Arock, Jean Pierre Kinet, Patrice Dubreuil, Alain Moussy

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

    Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial von Antoine Adenis, Jean‐Yves Blay, B. Bui-Nguyen, Olivier Bouché, François Bertucci, Nicolás Isambert, Emmanuelle Bompas, L. Chaigneau, Julien Dômont, Isabelle Ray‐Coquard, Aurore Blesius, Brian A. Van Tine, V.R. Bulusu, Patrice Dubreuil, Colin D. Mansfield, Y. Acin, Alain Moussy, Olivier Hermine, Axel Le Cesne

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

    Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial von Jesús S. Mora, Angela Genge, Adriano Chió, Conrado J. Estol, Delia Chaverri, Mariluz Hernández, Saúl Marín, Javier Mascías, Gabriel Rodríguez, Mònica Povedano, Andrés Paipa, Raúl Domínguez, Josep Gámez, María Salvadó, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean‐Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield, Olivier Hermine

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset

    Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset von Fanny Lanternier, Annick Cohen-Akenine, Fabienne Palmérini, Frédéric Féger, Ying Yang, Yaël Zermati, Stéphane Barète, B. Sans, Cédric Baude, David Ghez, Felipe Suárez, Richard Delarue, Philippe Casassus, Christine Bodemer, Adeline Catteau, Frédérique Soppelsa, Katia Hanssens, Michel Arock, Hagay Sobol, Sylvie Fraïtag, D. Canioni, Alain Moussy, Jean Marie Launay, Patrice Dubreuil, Olivier Hermine, Olivier Lortholary

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

    Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study von Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu, C. Paul, G. Guillet, Ewa Jassem, Marek Niedoszytko, Stéphane Barète, Srđan Verstovšek, Clive Grattan, Gandhi Damaj, Danielle Canioni, Sylvie Fraïtag, Ludovic Lhermitte, S. Georgin Lavialle, Laurent Frenzel, Lawrence B. Afrin, Katia Hanssens, Julie Agopian, Raphaël Gaillard, Jean-Pierre Kinet, Christian Auclair, Colin D. Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine

    Veröffentlicht 2017
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations

    Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations von Christine Bodemer, Olivier Hermine, Fabienne Palmérini, Ying Yang, Catherine Grandpeix‐Guyodo, Phillip S. Leventhal, S. Hadj‐Rabia, Laurent Nasca, Sophie Georgin-Lavialle, Annick Cohen-Akenine, Jean-Marie Launay, Stéphane Barète, Frédéric Féger, Michel Arock, B. Catteau, B. Sans, J.F. Stalder, Francois Skowron, L. Thomas, G Lorette, P. Plantin, Pierre Bordigoni, Olivier Lortholary, Y. De Prost, Alain Moussy, Hagay Sobol, Patrice Dubreuil

    Veröffentlicht 2009
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: